According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is 0,74ย โฌ. In 2022 the company made an earnings per share (EPS) of 0,73ย โฌ an increase over its 2021 EPS that were of -0,33ย โฌ.